Hosted on MSN
Entering the era of prenatal gene therapies
In February 2025, researchers at St Jude Children’s Research Hospital reported the first known in utero use of Roche’s spinal muscular atrophy (SMA) drug Evrysdi (risdiplam) in a human foetus. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback